The more useful question is not whether 5.7 is bad, it is what the number reflects and which direction it has been moving. This guide covers where that value sits against typical ranges, what the research does and does not show at this level, what pushes it up, which changes have the best evidence behind them, how long a change takes to appear on a lab report, and when the result deserves a conversation with a clinician.
Hemoglobin A1c measures the share of hemoglobin inside your red blood cells that has glucose attached to it, reported as a percentage. Because red cells circulate for roughly three months before being replaced, the result reflects average glucose exposure across that window rather than a single morning. It runs on a standard blood draw and does not require fasting.
Labs regard results above the typical reference range as a sign that average glucose has been running higher than usual, while unusually low results more often reflect red cell turnover or anemia than flawless glucose handling. The full detail on what the test is, how it is run, how its ranges are set and what high or low values can reflect lives on the biomarker page linked above. Everything below stays on one question, what a reading of 5.7% means and what changes it.
It sits at the very top of the standard lab reference range and at the first step of the band commonly categorized as prediabetes, which is why the same number can look reassuring on one report and flagged on another. Most clinical guidance regards 5.7 to 6.4 % as the prediabetes category, with 6.5 % or above on repeat testing as the threshold labs use for diabetes 1.
| Range | Value | What it represents |
|---|---|---|
| Standard lab reference range | 4 to 5.7 % | The typical reported range on a lab report |
| FitScript optimal range | 4.6 to 5.3 % | An optimization target, tighter than the lab range |
Reference ranges vary by lab, age and sex, and the figures above are typical lab reference ranges rather than universal cut-offs. FitScript's optimal range is an optimization target, not a diagnostic cut-off, so a value that falls inside the lab range but outside the optimal range is better described as suboptimal than abnormal.
One more point about precision. Laboratory assays carry a margin of measurement variation, so a sample that is truly near 5.7 can be reported slightly above or below it on a repeat draw. That is part of why a single borderline result is usually confirmed before anyone draws conclusions from it.
No single reading at 5.7% calls for alarm, but it does earn a second look rather than a shrug. Glucose risk is continuous. The numbers that define categories are administrative lines drawn across a smooth curve, so risk does not switch on at 5.7 and switch off at 5.6. What the threshold does well is flag the point where average glucose has drifted far enough that it is worth understanding why.
The practical reading of a 5.7 looks like this. The observation is that average glucose over the past few months has been running at the upper end of the usual range. That may reflect early insulin resistance, a dietary pattern heavy in refined carbohydrate, a stretch of low activity, poor sleep, weight gain around the midsection, or a non-glycemic factor such as iron deficiency. It may also reflect nothing more than normal variation in a person whose other metabolic markers are clean.
The next step is not panic and it is not dismissal. It is confirming the value, looking at it alongside related markers, and discussing the pattern with a clinician who can see the rest of your history. Research on prediabetes consistently frames this band as a risk state worth attention rather than a disease in itself 1.
Studies indicate that values in the prediabetes band are associated with a higher likelihood of progressing to type 2 diabetes than values well inside the normal range, and that progression is far from inevitable 2. A widely cited review described prediabetes as a high-risk state for diabetes development, noting that conversion rates are elevated but also that a meaningful share of people return to normal glucose regulation over time 2.
Risk at this level is also heterogeneous. Epidemiological work has pointed out that people grouped under the same label differ substantially in how their glucose behaves, in how much insulin resistance they carry, and in their actual outcomes, which is why the category alone is a poor predictor for any individual 3. Two people can both read 5.7 and have very different underlying physiology, one with mild insulin resistance and rising fasting insulin, another with normal insulin sensitivity and a red cell quirk.
The association also extends beyond blood sugar. Research links dysglycemia in this range with cardiovascular risk markers, though how much of that association is driven by glucose itself rather than the clustering of blood pressure, lipids and central adiposity that often travels with it remains debated 3. The honest summary is that 5.7 raises the probability of a worse metabolic trajectory without saying anything certain about your trajectory, and that is exactly the kind of signal that is actionable early.
Results in this band are common, and common is not the same as harmless or inevitable. Research on global prevalence indicates that prediabetes affects a large and growing share of adults worldwide, with estimates differing substantially depending on whether the definition uses A1c, fasting glucose or an oral glucose tolerance test 4. Those three tests do not identify the same people, which is one of the reasons prevalence figures vary so widely.
There are two ways people misread the commonness of this result. The first is to treat it as reassurance, as though a widely shared number cannot matter. The second is to treat it as a sentence, as though being in a large group means following the group's worst outcome. Neither holds. What the prevalence data supports is a more modest point, that a reading of 5.7 is an ordinary finding that deserves an ordinary, unhurried follow-up rather than either dismissal or dread.
It is also worth knowing that a result in this range becomes more likely with age, which is why a 5.7 in a 30-year-old and a 5.7 in a 65-year-old can warrant different conversations even though the number is identical.
Yes, because the test depends on red blood cells, anything that changes how long those cells survive can shift the result independently of your actual glucose. This is the single most overlooked reason a borderline value should be confirmed rather than acted on alone.
| Factor | What labs consider about its effect on A1c |
|---|---|
| Iron deficiency anemia | Associated with readings that look higher than average glucose would predict |
| Recent blood loss, hemolysis or recent transfusion | May pull the reading lower than average glucose would predict |
| Pregnancy | Red cell turnover shifts, so results are interpreted against pregnancy-specific guidance |
| Chronic kidney disease or advanced liver disease | Can move results in either direction |
| Hemoglobin variants | May interfere with some assay methods, so the lab's method matters |
| Living at high altitude or recent blood donation | Can alter red cell turnover and shift the reading |
None of these factors make the test unreliable in general. They make it one number among several, and they explain the common scenario where a reader with a 5.7 has a completely normal fasting glucose and no symptoms. If any of these apply, a clinician may lean more heavily on a glucose-based measure. In people with hemoglobin variants in particular, the laboratory method used can matter more than the value printed on the report.
The single most useful companions are a glucose measure and an insulin measure, because together they separate how high your sugar is from how hard your body is working to keep it there. Fasting Glucose captures a single morning snapshot, and comparing it with A1c often surfaces a mismatch worth explaining, for example a 5.7 with a clean fasting glucose, which can point to post-meal excursions or a red cell factor.
Fasting Insulin adds the piece A1c cannot see. Insulin resistance can build for years while glucose stays inside range, because the pancreas compensates by producing more insulin. Research on the pathobiology of dysglycemia describes this compensation phase and its eventual decline as the central mechanism behind progression, which is why a rising insulin with a stable A1c is informative rather than reassuring 6.
Beyond those three, the markers clinicians commonly look at alongside a borderline A1c include triglycerides and HDL cholesterol, liver enzymes such as ALT, and markers of inflammation, because central adiposity, fatty liver and dysglycemia tend to cluster. Blood pressure and waist measurement belong in the same picture and cost nothing to collect. A broader panel does not change what 5.7 means on its own, it changes how confidently you can interpret it, and it gives a clinician something to work with other than one borderline percentage.
A1c rises when average glucose rises, and average glucose rises when the demand on insulin outstrips what the body can supply or respond to. A systematic review of progression risk in prediabetes identified a familiar cluster of contributors, including higher body weight and central adiposity, older age, family history and co-existing metabolic abnormalities 5. None of those operate in isolation.
The mechanism underneath is worth understanding because it explains why lifestyle changes work. Excess fat stored in and around the liver and muscle interferes with insulin signalling, so the same meal requires more insulin to clear. For a while the pancreas keeps up and glucose stays normal. Over time beta cell function declines and glucose begins drifting upward, first after meals, then in the fasting state. Research describing this progression frames it as a gradual, partly interruptible process rather than a switch 6.
Day-to-day inputs feed the same system. Short sleep and disrupted circadian timing are associated with reduced insulin sensitivity. Prolonged sitting reduces how much glucose muscle pulls out of the blood. A dietary pattern built on refined carbohydrate and liquid sugar produces larger post-meal excursions. Chronic stress and high cortisol exposure raise glucose output from the liver. Some prescription medications, including steroid courses, are associated with higher glucose while they are in use, a point for the prescribing clinician rather than something to adjust on your own.
Combined diet and physical activity interventions carry the strongest evidence 7. A systematic review and meta-analysis of interventions in prediabetes found that structured lifestyle programs were associated with a greater likelihood of returning glucose measures to the normal range than usual care, with dietary change and activity working better together than either alone 7.
On the exercise side, a network meta-analysis comparing training modalities in prediabetes reported benefits across aerobic training, resistance training and combined approaches, and the practical takeaway is that the format you will actually sustain matters more than picking a theoretically optimal one 8. Resistance training adds muscle mass, which expands the tissue available to dispose of glucose. Aerobic work improves insulin sensitivity in the hours and days after a session, which is why frequency tends to matter more than any single long effort.
The food side is less about a named diet than about a few repeatable levers. Reducing refined carbohydrate and sugar-sweetened drinks lowers post-meal glucose spikes. Protein and fibre at each meal blunt the same spikes. Modest weight loss, particularly from the abdominal region, is consistently associated with improved insulin sensitivity. A short walk after meals is one of the few interventions that is both well supported and genuinely easy to adopt. Sleep and alcohol belong on the list too, since both influence glucose handling more than most people expect.
Probably yes, because the physiology that drives a borderline A1c also drives other cardiometabolic markers. A study of a digital diabetes prevention program among individuals with prediabetes reported improvements in cardiovascular risk factors alongside glycemic measures, which supports the idea that the benefits of this work are not limited to one line on a lab report 9.
That matters for motivation. Chasing a tenth of a percentage point on a single marker is a thin reason to change how you eat and move. Improving blood pressure, triglycerides, liver fat, body composition and energy at the same time is a much better one, and those changes tend to arrive together because they share a root. Results here are averages rather than individual guarantees, and no program can promise a specific outcome for a specific person.
Roughly three months, because that is how long red blood cells circulate, and more recent weeks carry more weight in the result than older ones. This single fact explains most of the frustration people feel after changing their habits and retesting too soon.
If you overhaul your diet and start training this week, your fasting glucose can respond within days and your post-meal glucose can respond within a single meal. Your A1c will barely budge for a few weeks, because the majority of your red cells are still carrying the glycation history of the period before you changed anything. Retesting at four or six weeks usually produces a number that mostly reflects measurement variation plus the old pattern, which reads as failure when it is really just timing.
The practical approach is to use fast-moving markers for feedback and A1c for confirmation. Fasting glucose, waist measurement, training performance and how you feel after meals give you weekly signal. A1c gives you a quarterly verdict. A clinician will usually set the retest interval, and around three months is the common choice for a reason that is biological rather than arbitrary.
At minimum yearly for someone sitting in this band, and sooner when a change is being made deliberately or when other risk factors are present. Reviews of screening practice describe repeat testing at regular intervals for people whose results fall in the prediabetes range, with the interval shortened when risk factors cluster 10. Your clinician sets the schedule based on your full picture, not on the number alone.
There is also a difference between rechecking to confirm and rechecking to track. Confirmation usually happens soon after a borderline first result, often alongside a fasting glucose, to rule out assay variation or a red cell factor. Tracking happens on a slower cadence, long enough apart that the number has had time to move.
One more consideration. Comparing A1c results run by different laboratories, or on different assay platforms, introduces variation that has nothing to do with your metabolism. Where possible, tracking through the same lab makes the trend line more trustworthy than any individual value on it.
It can add resolution that A1c cannot provide, though its value at this level is not yet settled. A review of continuous glucose monitoring in prediabetes described its potential roles in revealing post-meal glucose excursions and day-to-day variability that an average conceals, while also identifying real gaps in the evidence for whether that information improves outcomes in this population 11.
The appeal is obvious. A 5.7 tells you the average was elevated. A sensor can show you which meals, which times of day and which behaviours drive the peaks, which turns an abstract number into specific feedback. For people who respond well to immediate feedback, that can make dietary changes easier to stick with.
The cautions are equally real. Sensors carry their own measurement error, normal glucose fluctuates more than most people assume, and a reading that looks alarming in isolation often is not. Interpreting the data without a framework can produce anxiety and unnecessarily restrictive eating. It may be a useful educational tool for the right person, and it is best used with clinician input rather than as a substitute for standard testing.
It generally warrants closer attention, because dysglycemia that appears early tends to progress faster. Research on prediabetes and type 2 diabetes in youth describes more rapid beta cell decline and a more aggressive clinical course than is typically seen in adults with comparable values, which argues for prompt clinical evaluation rather than a wait-and-see approach 12.
The same logic applies in a softer form across adulthood. A 5.7 in your twenties or thirties means the drift started early, and it leaves decades of runway for either improvement or progression. A 5.7 later in life sits against a background where some upward movement in glucose is expected with age, and where the decision about how aggressively to intervene depends more on overall health, other risk factors and goals.
In children and adolescents, any result in this range belongs with a pediatric clinician. The evaluation differs, growth and puberty influence insulin sensitivity, and the appropriate next steps are not the same as for adults.
Always worth raising at your next visit, and worth raising promptly if symptoms are present. Increased thirst, frequent urination, unexplained weight loss, blurred vision, recurrent infections or unusual fatigue alongside a borderline or rising result are reasons to contact a clinician promptly rather than waiting for a scheduled appointment. The same applies when a result has climbed noticeably between tests, or when you are pregnant or planning pregnancy, since glucose is assessed differently in that context.
Bring the surrounding information with you, not just the one value. Previous A1c results, a recent fasting glucose, any history of anemia or iron deficiency, family history, current medications and a plain description of your sleep, activity and eating pattern give a clinician far more to work with than a single percentage. Questions about any prescription option belong with the prescribing clinician, who evaluates whether it is appropriate after reviewing you as a whole person. Never ignore an abnormal or borderline result on the assumption that it is minor, and never make medication changes on your own.
This guide is educational and not medical advice. Discuss your results and any treatment decisions with a clinician or licensed provider who can see your full history.
For a wider view of the metabolic picture this marker sits inside, the Metabolic + Insulin panel groups glucose, insulin and the related markers clinicians read together, and FitScript builds member interpretation on 150+ biomarkers tested per year, reviewed with Atlas, its AI health advisor. If your next step is the practical side rather than the interpretation side, the guide to how to lower your A1c goes deeper on the day-to-day levers.
It is the first value in the band most guidelines categorize as prediabetes, which runs from 5.7 to 6.4 %. A single reading does not establish a diagnosis, since assay variation and red cell factors can both influence it, so confirmation and a clinician's review come first.
Often, yes. Combined diet and activity changes are associated with a greater likelihood of glucose measures returning to the normal range than usual care. No intervention guarantees a specific result, and the size of the change varies from person to person.
Expect around three months, because red blood cells circulate for roughly that long and the result reflects their glycation history. Retesting at four or six weeks mostly captures the previous pattern plus measurement noise. Fasting glucose responds much faster if you want earlier feedback.
No. The risk of progression is higher than for values well inside the normal range, but progression is not inevitable and outcomes in this group vary widely. The number raises a probability, it does not predict your individual future.
No. Because the test reflects average glucose over roughly three months rather than your current level, fasting is not required. That convenience is one reason it is used for screening. A fasting glucose drawn at the same visit does require fasting.
Yes. Iron deficiency anemia is associated with readings that look higher than average glucose would predict, while recent blood loss, hemolysis or a recent transfusion can pull the reading lower. This is one reason a borderline value is usually interpreted alongside a glucose measure.
The two tests measure different things. Fasting glucose captures one morning, while A1c averages months and includes post-meal excursions a morning draw never sees. A red cell factor can also explain the gap. Both results together are more informative than either alone.
It is a reasonable question for your clinician. Insulin resistance can build while glucose stays in range, because the pancreas compensates with more insulin. A fasting insulin alongside glucose and A1c shows how much work is going into keeping the number where it is.